SALLYNOGGIN-based first aid product developer Alltracel Pharmaceuticals has signed a major deal with the Yunnan Baiyao Group, China’s largest consumer wound care company.

SHARES in Alltracel Pharmaceuticals surged 10% yesterday after the Sallynoggin-based first aid product developer issued a positive trading update.

ALLTRACEL has signed an agreement with a technology specialist in the Czech Republic.

FLEDGLING pharmaceutical company Alltracel has reported positive news from tests of its m-doc product as a cholesterol-reducing agent in food.

FLEDGLING pharmaceutical company Alltracel continued to make steady progress yesterday by announcing full-year revenues of €4.6 million, up from €1m in 2003.

ALLTRACEL shares surged 14% yesterday after the pharmaceutical company announced a major new product breakthrough.

A SENIOR executive with a Dublin-based pharmaceutical company has sold his entire stake in the firm to fund the separation from his wife.

ALLTRACEL pharmaceuticals has announced plans to splash out up to €8 million for a London-based specialist dental care company.

FIRST AID product developer Alltracel Pharmaceuticals remained on track to meet analysts forecasts when it reported strong third-quarter revenues of €0.7 million yesterday, up from €0.1 million in the same period last year.

Bio-pharmaceutical group Alltracel has announced third quarter revenues of €700,000.

SHARES in Alltracel Pharmaceuticals rose more than 2% yesterday after the fledgling Dublin-based first aid product developer completed a €6.8 million fundraising round.

IRISH companies looking to expand quickly should list on London's Alternative Investment Market (AIM), the exchange's deputy head told entrepreneurs in Dublin yesterday.

ALLTRACEL Pharmaceuticals founder and chief executive Gerry Brandon is to step down, the first aid product developer said yesterday.

SHARES in Alltracel Pharmaceuticals rose by 6% yesterday after the fledgling Dublin-based first aid product developer announced two major deals with leading names in the industry.

Alltracel Pharmaceuticals said its first quarter revenue was €857,000, up 340% over first quarter 2003 revenues and more than double last quarter’s record revenue result.

Irish pharmaceutical firm Alltracel has released much improved 2003 results with full year revenue up 61% to €1.01m.

DUBLIN-BASED pharmaceutical company Alltracel moved into the €1 billion Asia Pacific market yesterday by signing a deal with a leading first aid manufacturer in the region.

Dublin-based pharmaceutical company Alltracel said yesterday that chemists chain Boots plans to sell its blood-stopping first-aid products in its shops.

The money raised on the AIM (alternative investment markets) in London this year will be almost equal as the amount raised on the main UK stock exchange, with companies seeking to exploit the junior market's lower costs and lighter regulation.

Aim listed, Irish pharmaceutical firm Alltracel, has raised £4m (€5.74m) in a share issue from a private placement .

ALLTRACEL Pharmaceuticals, the Dublin-based manufacturer of anti-bleeding and wound-care products, will continue its strong share price momentum, according to research published last week by Davy stockbrokers.